AllianceBernstein’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489K Sell
41,980
-18,140
-30% -$174K ﹤0.01% 2646
2025
Q4
$700K Sell
60,120
-2,581,991
-98% -$25.1M ﹤0.01% 2498
2025
Q3
$26.6M Sell
2,642,111
-1,183,682
-31% -$17M 0.01% 826
2025
Q2
$66.8M Sell
3,825,793
-97,012
-2% -$1.4M 0.02% 530
2025
Q1
$49.3M Buy
3,922,805
+42,071
+1% +$506K 0.02% 590
2024
Q4
$40.9M Buy
3,880,734
+3,807,074
+5,168% +$53.3M 0.01% 656
2024
Q3
$1.07M Hold
73,660
﹤0.01% 2290
2024
Q2
$627K Buy
73,660
+14,490
+24% +$129K ﹤0.01% 2539
2024
Q1
$605K Sell
59,170
-3,620
-6% -$27K ﹤0.01% 2501
2023
Q4
$344K Hold
62,790
﹤0.01% 2783
2023
Q3
$237K Buy
62,790
+38,010
+153% +$249K ﹤0.01% 2901
2023
Q2
$166K Buy
+24,780
New +$165K ﹤0.01% 3018
2021
Q3
Sell
-7,300
Closed -$225K 3336
2021
Q2
$225K Buy
+7,300
New +$234K ﹤0.01% 3122

Other funds holding SPRY